Skip to main content
SpringerLink
Log in

Muskelerkrankungen

  • Chapter
Therapie der Krankheiten des Kindesalters

  • 28 Accesses

Zusammenfassung

Jeder Skelettmuskel kann isoliert oder in Kombination mit anderen bei der Geburt fehlen oder hypoplastisch sein. Am häufigsten betroffen sind der Reihenfolge nach der M. pectoralis, der M. trapezius, M. quadratus femoris und der M. serratus anterior. Die Anomalien sind meist einseitig. Die Beeinträchtigung der Patienten ist abhängig von der funktionellen Bedeutung des betreffenden Muskels; Wirbelsäulen- und Gelenksdeformierungen, Thoraxasymmetrie sowie Haltungs- und Bewegungsstörungen können die Folge sein. Die Ätiologie der Muskeldefekte ist unbekannt, familiäre Häufung bestimmter Defekte kommt vor. Pathogenetisch kann es sich ebenso um Störungen der spinalen Motoneurone oder der peripheren Nerven handeln wie um primäre Störungen der Muskelzellen in der frühen Fetalperiode, etwa vor der 9.–10. Lebenswoche

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bell JF, Kuhlmann RF, Molloy MK (1967) Congenital defects of shoulder girdle, sternum, spine and pelvis. Pediatr Clin N Am 14: 397

    CAS  Google Scholar 

  2. Becker PE (1964) Angeborene Muskeldefekte. In: Becker PE (Hrsg) Humangenetik, Bd III/1. Thieme, Stuttgart, S 527–534

    Google Scholar 

  3. Bernbeck R, Dahmen G (1976) Deformitäten im 8. SchröderJM (1982) Pathologie der Muskulatur. Schulterbereich. Thieme, Stuttgart, S 280–285 Springer, Berlin Heidelberg New York, S 387–388

    Google Scholar 

  4. Dick W, Jani L (1976) Die konservative Frühbe- 9. Tachdjian MO (1967) Diagnosis and treatment of handlung des muskulären Schiefhalses. Orthopädi congenital deformities of the musculoskeletal sys-sche Praxis 12: 866 tem in the newborn and the infant. Pediatr Cl in N

    Google Scholar 

  5. Gucker T (1967) Muscular defects. Pediatr Clin N Am 14: 307 Am 14: 439 10.

    Google Scholar 

  6. Welch KK (1966) Abdominal musculature deficien-6. Nelson KB, Eng GD (1972) Congenital hypoplasie cy syndrom. In: Mustard WT et al. (eds) Pediatric of the depressor anguli oris muscle. Differentiation surgery, 2nd edn, vol 2. Year Book Medical Publ., from congenital facial palsy. J Pediatr 81: 16–20 New York, pp 1191–1203

    Google Scholar 

  7. Sarnat HB, Morrissy RT (1981) Idiopathic torti- 11. Wirth CJ, Hagena FW (1983) Der muskuläre collis: Sternocleidomastoid myopathy. Muscle Schiefhals. In: Aktuelle Probleme in Chirurgie und Nerve 4: 374–380

    Google Scholar 

  8. Schröder JM (1982) pathologie der Muskulatur. Springer, Berlin Heidelberg New York, S387–388

    Book  Google Scholar 

  9. Tachdjian MO(1967) Diagnosis and treatment of comgnital deformities of the musculoskeletal system in the newborn and the infant. Pediatr Clin N Am 14:307

    Google Scholar 

  10. Welch KK (1966) Abdominal musculature deficiency syndrome. In: Mustard WT et al. (eds) Pediatric surgery, 2 nd edn, vol 2. Yeat Book Medical Publ., New York, pp 1191–1203

    Google Scholar 

  11. Wirth CJ, Hagena FW (1983) Der muskuläRT Schiefhals. In: Aktuelle Probleme in Chirurgie und Orthopädie, Bd 27. Huber, Bern Stuttgart Wien

    Google Scholar 

  12. Dubowitz V (1969) The floppy infant. In: Clinics in developmental medicin, Nr. 31. Spastics Intern. Med. Publ. Heinemann, London

    Google Scholar 

  13. Hirt HR (1973) Muskeltonus. In: Matthes A, Kruse R (Hrsg) Neuropädiatrie. Thieme, Stuttgart, S 67

    Google Scholar 

  14. Stephanie U, Hanefeld F (1981) Muskuläre Hypotonie im Kindesalter - Pathophysiologie und Klinik. In: Ewerbeck H (Hrsg) Pädiatrie, Weiter- und Fortbildung. Springer, Berlin Heidelberg New York, S 40–82

    Google Scholar 

  15. Becker PE (1972) Neues zur Genetik und Klassifikation der Muskeldystrophien. Hum Genet 17: 1

    Article  CAS  Google Scholar 

  16. Chyatte SB, Rudman D, Patterson JH, Gerron GG, O’Breine I, Jordan A, Shavin JS (1973) Human growth hormone and estrogens in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabi154: 248

    Google Scholar 

  17. Cohen L, Morgan J, Balsamo R (1974) Duchenne’s muscular dystrophy: Serum enzyme and isoenzyme changes associated with diethylstilbestrol administration. Int Congr on muscular diseases. Excerpta Medical, Amsterdam Princeton London Geneva Tokyo, p 157

    Google Scholar 

  18. Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet II: 1409

    Google Scholar 

  19. Dubowitz V (1978) Muscle disorders in childhood. Saunders, London Philadelphia Toronto, p 19

    Google Scholar 

  20. Emery AEH, Skinner R, Howden LC, Matthews MB (1982) Verapamil in Duchenne muscular dystrophy. Lancet I: 559

    Google Scholar 

  21. Heyck H, Laudahn G (1969) Die progressiv-dystrophischen Myopathien. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  22. Mortier W (1981) Progressive Muskeldystrophien. In: Hopf HC et al. (Hrsg) Neurologie in Klinik und Praxis. Thieme, Stuttgart, S 134–162

    Google Scholar 

  23. Rideau Y (1984) The treatment of scoliosis in Duchenne muscular dystrophy. Muscle Nerve 7: 281–286

    Article  PubMed  CAS  Google Scholar 

  24. Ringel SP, Stern LZ et al. (1980) Randomized, double-blind, placebo-controlled trial of ontosein (su-peroxyde dismutase) in Duchenne muscular dystrophy. In: Angelini C, Danieli GA, Hontanari D (eds) Muscular dystrophy research: Excerpta Medica, Amsterdam Oxford Princeton, p 198

    Google Scholar 

  25. Siegel JM (1977) Prolongation of ambulation through early percutaneous tenotomy and bracing with plastic orthoses. Israel J Med Sci 13: 192

    PubMed  CAS  Google Scholar 

  26. Siegel IM (1978) The management of muscular dystrophy. A clinical review. Muscle Nerve 1: 453

    Article  PubMed  CAS  Google Scholar 

  27. Stern ML, Fewings JD et al. (1981) The progression of Duchenne muscular dystrophy: Clinical trial of allopurinol therapy. Neurology (NY) 31: 422–426

    Google Scholar 

  28. Walton JN, Gardner-Medwin D (1981) Progressive muscular dystrophy and myotonic disorders. In: Walton JN (ed) Disorders of voluntary muscle. Churchill-Livingstone, Edinburgh London, p 481

    Google Scholar 

  29. Birnberger KL, Rtidel R (1974) Improvement of myotonic disorders with N-propyl-ajmaline and its possible neurophysiologic basis. In: Bradley WG (ed) Internat. Congress Series Nr. 334. Excerpta Medica, Amsterdam Princeton London Geneva Tokyo, p 157

    Google Scholar 

  30. Britt BA (1982) Malignant hyperthermia: a review. In: Milton AS (ed) Pyretics and antipyretics. Springer, Berlin Heidelberg New York (Handb Exp Pharmacol, vol 60, pp 547–615 )

    Google Scholar 

  31. Dalakas MC, Engel WK (1983) Treatment of „permanent“ muscle weakness in familial hypocalemic periodic paralysis. Muscle Nerve 6: 182–186

    Article  PubMed  CAS  Google Scholar 

  32. Durelli L, Mutani R, Fassio F, Sarra A, Bartoli E (1982) Taurine and hyperexitable human muscle: Effects of taurine on potassium-induced hyperexcita-bility of dystrophic myotonic and normal muscles. Ann Neurol 11: 258–265

    Google Scholar 

  33. Engel AG, Siekert RG (1972) Lipid storage myopathy responsive to prednisone. Arch Neurol (Chic) 27: 174

    Article  CAS  Google Scholar 

  34. Lehmann-Horn F, Rudel R, Ricker K, Lorkovic H, Dengler R, Hopf HC (1983) Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve 6: 113–121

    Article  PubMed  CAS  Google Scholar 

  35. McArdle B (1974) Metabolic and endocrine myopathies. In: Walton JN (ed) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh London, p 726

    Google Scholar 

  36. Mortier W (1981) Kongenitale Myopathien und Muskelhypotonie. In: Hopf HC et al. (Hrsg) Neurologie in Klinik und Praxis. Thieme, Stuttgart, p 1.3–1. 33

    Google Scholar 

  37. Mortier W, Biesel C (1982) Pharmacological in-vitro Studies in malignant hyperthermia in childhood. Brain Dev 4: 347–52

    Article  PubMed  CAS  Google Scholar 

  38. Ricker K, Böhlen R, Rohkamm R (1983) Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. Neurology (Cleveland) 33: 1615–1618

    Article  CAS  Google Scholar 

  39. Rudel R, Lehmann-Horn F, Ricker K, Kiither G (1984) Hypokalemic periodic paralysis: In vitro in-vestigation of muscle fiber membrane parameters. Muscle Nerve 7: 110–120

    Google Scholar 

  40. Schimrigk K (1981) Metabolische Myopathien. In: Hopf HC et al. (Hrsg) Neurologie in Klinik und Praxis. Thieme, Stuttgart, S 1.96–1. 109

    Google Scholar 

  41. Scholte HR, Meijer AEFH, van Wijngaarden GK, Leenders KL (1979) Familial carnitine deficiency. J Neurol Sci 42: 87

    Article  PubMed  CAS  Google Scholar 

  42. Schrott E, Karo L, Osmann GS (1973) Prenatal prediction in myotonic dystrophy: guidelines for genetic counseling. Clin Genet 4: 38

    Article  PubMed  CAS  Google Scholar 

  43. Schuh FT (1981) Maligne Hyperthermie, Soforttherapie und Vorgehen bei erneuter Narkose. Dtsch Med Wochenschr 106: 1431–1432

    Article  PubMed  CAS  Google Scholar 

  44. Stovner J, Innes KR, Holen A (1976) Ten cases of malignent hyperthermia in Norway. Can Anaesth Soc J 23: 518

    Article  PubMed  CAS  Google Scholar 

  45. Viskoper RJ, Wolf E, Chaco J, Katz R, Chowers J (1975) McArdle’s Syndrome: the reaction to a fatrich diet. Am J Med Sci 269: 217

    Article  PubMed  CAS  Google Scholar 

  46. Yates DAH (1970) Steroid myopathy. In: Walton JN, Canal N, Scarlato G (Eds) Muscle diseases. Excerpta Medica, Amsterdam, pp 482–488

    Google Scholar 

  47. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292: 344, 403

    Article  PubMed  CAS  Google Scholar 

  48. Dau PC, Bennington JL (1981) Plasmapheresis in 8. childhood dermatomyositis. J Pediatr 98: 237–240

    Article  PubMed  CAS  Google Scholar 

  49. Dubowitz V (1978) Muscle disorders in childhood. 9. Saunders, London Philadelphia Toronto, p 202

    Google Scholar 

  50. Fischer TJ, Rachelefsky GS, Klein RB, Paulus HE, Stiehm ER (1979) Childhood dermatomyositis and polymyositis. Am J Dis Child 133: 386 10.

    Google Scholar 

  51. Jacobs JC (1977) Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 59: 212 11.

    Google Scholar 

  52. Mertens HG, Lurati M (1975) Immunsuppressive Behandlung der polymyositis. Dtsch Med Wochenschr 100: 1

    Article  Google Scholar 

  53. Metzger AL, Bohan A, Goldberg LS et al. (1974) Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med 81: 82

    Article  Google Scholar 

  54. MillerJJ (1973) Late progression in dermatomyositis in childhood. J Pediatr 83: 543

    Article  PubMed  Google Scholar 

  55. Schnakenburg von K, Groß-Selbeck G, Wiedemann HR (1972) Zur Behandlung der Fibrodysplasia ssificans progressiva mit „Diphosphonat“ ( EHDP ). Dtsch Med Wochenschr 97: 1873

    Google Scholar 

  56. Skuterud E, Sydnes OA, Haavik TK (1981) Calcinosis in dermatomyositis treated with probenecid. Scand J heumatol 10: 92–94

    Article  CAS  Google Scholar 

  57. Stögmann W (1972) Erfahrungen in der Behandlung der Dermatomyositis mit Immunsuppressiva. Pädiatr ädiol 7: 305

    Google Scholar 

  58. Fenichel GM (1978) Clinical syndromes of myasthenia in infancy and childhood. A review. Arch Neurol 35: 97–103

    Article  PubMed  CAS  Google Scholar 

  59. Fischer KC, Schwartzmann RI (1974) Oral corticosteroids in the treatment of ocular myasthenia. Neurology (Minneap) 24: 364

    Article  Google Scholar 

  60. Fonkalskud EW, Herrmann C jr, Mulder DG (1970) Thymectomie for myasthenia gravis in children. J Pediatr Surg 5: 157

    Article  Google Scholar 

  61. Hansson O, Johannsson L, Stalberg E, Wester-holm CJ (1972) Thymektomie in juvenile myasthenia gravis. Neuropädiatrie 3: 429

    Article  Google Scholar 

  62. Hertel G, Mertens HG, Ricker K, Schimrigk K (1977) Myasthenia gravis. Thieme, Stuttgart

    Google Scholar 

  63. Karch D, Mortier W, Kauther K (1981) Therapeutische Probleme bei der Myasthenia gravis im Kindesalter. In: Hirt HR (Hrsg) Aktuelle Neuropädiatrie, Bd III. Thieme, Stuttgart, S 170–176

    Google Scholar 

  64. Newsom-Davis J, Pinching Ai, Vincent A et al. (1978) Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange. Neurology 28: 266–272

    Google Scholar 

  65. Ryniewicz O, Badurska B (1977) Follow-up study of myasthenic children after thymectomy. J Neurol 217 /2: 133

    Article  PubMed  CAS  Google Scholar 

  66. Sarnat HB, McGarry JD, Lewis JE (1977) Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy. Neurology 27 /6: 550

    Article  PubMed  CAS  Google Scholar 

  67. Seybold ME, Lindstrom JM (1981) Myasthenia gravis in infancy. Neurology (NY) 31: 476–480

    CAS  Google Scholar 

Download references

Authors
  1. W. Mortier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Kinderheilkunde der Universität, Moorenstr. 5, D-4000, Düsseldorf, Deutschland

    Gustav-Adolf von Harnack

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mortier, W. (1985). Muskelerkrankungen. In: von Harnack, GA. (eds) Therapie der Krankheiten des Kindesalters. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10467-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10467-5_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10468-2

  • Online ISBN: 978-3-662-10467-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation